Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.61
0.26 (5.98%)
At close: Aug 15, 2025, 3:07 PM
Monte Rosa Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 69.43M | 78.53M | 224.25M | 125.58M | 108.85M | 99.75M | 128.1M | 59.05M | 47.03M | 51.85M | 54.91M | 112.39M | 103.66M | 138.31M | 346.07M | 367.03M | 357.06M | 168.44M |
Short-Term Investments | 221.16M | 247.54M | 147.9M | 116.61M | 153.36M | 93.14M | 104.31M | 119.42M | 156.04M | 179.89M | 207.91M | 159.75M | 190.48M | 178.86M | n/a | n/a | n/a | n/a |
Long-Term Investments | 4.95M | n/a | n/a | 4.91M | 4.87M | 4.86M | 4.58M | n/a | 4.53M | 4.32M | 4.32M | 4.3M | 5.32M | 5.33M | 5.34M | 1.73M | 1.73M | 1.16M |
Other Long-Term Assets | 445K | 5.32M | 4.98M | 159K | 209K | 389K | 352K | 4.79M | 291K | 351K | 278K | 148K | 384K | n/a | n/a | n/a | n/a | n/a |
Receivables | 2.37M | 1.41M | 173K | 595K | 9.84M | 601K | 505K | 294K | 1.15M | 2.17M | 7.66M | 17.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 960K | 960K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.5M | 4.8M | 5.12M | 8.43M | 5.85M | 5.54M | 3.29M | 4.14M | 3.88M | 6.65M | 5.4M | 960K | 2.9M | 3.2M | 2.6M | 3.48M | 1.23M | n/a |
Total Current Assets | 299.46M | 332.28M | 377.44M | 251.21M | 277.9M | 199.04M | 236.21M | 182.91M | 208.1M | 240.56M | 275.89M | 295.24M | 297.05M | 320.37M | 348.67M | 370.52M | 358.29M | 171.71M |
Property-Plant & Equipment | 54.73M | 55.6M | 56.31M | 58.81M | 61.14M | 62.46M | 62.61M | 64.4M | 65.69M | 63.8M | 61.91M | 57.92M | 62.31M | 20.31M | 12.32M | 11.8M | 8.92M | 7.73M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 60.12M | 60.92M | 61.29M | 63.87M | 66.22M | 67.71M | 67.54M | 69.19M | 70.51M | 68.47M | 66.5M | 62.37M | 68.01M | 25.64M | 17.66M | 13.53M | 10.65M | 8.9M |
Total Assets | 359.59M | 393.2M | 438.73M | 315.08M | 344.11M | 266.75M | 303.75M | 252.1M | 278.62M | 309.03M | 342.39M | 357.6M | 365.06M | 346M | 366.33M | 384.05M | 368.94M | 180.6M |
Account Payables | 5.58M | 6.49M | 17.21M | 3.98M | 6.47M | 6.83M | 11.15M | 5.5M | 5.31M | 7.38M | 7.86M | 9.75M | 4.29M | 4.51M | 6.56M | 3.53M | 7.46M | 7.33M |
Deferred Revenue | 18.41M | 32.58M | 117.23M | 18.92M | 19.64M | 20.41M | 17.68M | n/a | 8.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 4.09M | n/a | n/a | n/a | n/a | 3.35M | 3.16M | 2.88M | 2.67M | 2.89M | 3.13M | 3.06M | 2.66M | 1.52M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.64M | 8.26M | 11.57M | 15.1M | 7.62M | 3.83M | 6.1M | 27K | 4.25M | 4.12M | 7.52M | -3.06M | -2.66M | -1.52M | 840K | n/a | n/a | n/a |
Total Current Liabilities | 41.85M | 59.22M | 156.95M | 41.64M | 42.35M | 41.29M | 46.59M | 22.61M | 19.09M | 20.52M | 25.57M | 21.79M | 14.77M | 12.49M | 16.64M | 12.74M | 10.79M | 9.09M |
Long-Term Debt | 37.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 231.17M |
Other Long-Term Liabilities | 4.56M | 3.96M | 3.7M | 2.82M | 2.61M | 2.57M | 2.71M | 1.45M | 1.5M | 1.51M | 1.53M | 2.13M | 2.14M | 2.18M | 2.18M | 2M | 1.47M | n/a |
Total Long-Term Liabilities | 49.65M | 58.82M | 58.85M | 67.98M | 77.09M | 72.93M | 77.91M | 44.97M | 45.87M | 44.79M | 45.41M | 44.72M | 48.23M | 7.64M | 2.18M | 2M | 1.47M | 232.13M |
Total Liabilities | 91.51M | 118.04M | 215.8M | 109.62M | 119.44M | 114.23M | 124.5M | 67.58M | 64.96M | 65.3M | 70.98M | 66.51M | 63.01M | 20.13M | 18.81M | 14.74M | 12.26M | 241.22M |
Total Debt | 41.13M | 41.86M | 42.72M | 43.7M | 44.36M | 45.18M | 46.04M | 46.4M | 47.03M | 46.16M | 47M | 45.66M | 48.76M | 6.98M | n/a | n/a | n/a | 231.17M |
Common Stock | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 1K |
Retained Earnings | -404M | -391.7M | -438.59M | -452.02M | -428.17M | -397.86M | -365.89M | -332.64M | -297.75M | -262.57M | -230.54M | -199.75M | -172.44M | -145.97M | -122.03M | -98.59M | -78.76M | -60.35M |
Comprehensive Income | -3.37M | -3.33M | -3.36M | -2.32M | -2.67M | -2.69M | -2.72M | -1.46M | -1.64M | -1.39M | -1.75M | -2.6M | -2.46M | -2.13M | -2.02M | -1.95M | -1.42M | -920K |
Shareholders Equity | 268.08M | 275.16M | 222.94M | 205.46M | 224.67M | 152.52M | 179.25M | 184.52M | 213.65M | 243.73M | 271.41M | 291.09M | 302.05M | 325.88M | 347.51M | 369.31M | 356.68M | -60.62M |
Total Investments | 226.12M | 247.54M | 147.9M | 116.61M | 158.22M | 98M | 108.89M | 119.42M | 156.04M | 179.89M | 207.91M | 159.75M | 190.48M | 178.86M | 5.34M | 1.73M | 1.73M | 1.16M |